Targeted therapy sorafenib shows success in advanced differentiated thyroid cancer patients (EurekAlert, 2 June 2013)

03 Jun 2013


Results of a multicenter, international trial of sorafenib (Nexavar) for thyroid cancer patients whose tumours progress following standard therapies are presented at the annual American Society of Clinical Oncology meeting.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story